surmount study tirzepatide for Obesity Treatment and Diabetes Prevention Effect of tirzepatide treatment on

In recent clinical trials in persons with obesity or overweight with associated conditions, tirzepatide decreased body weight and other cardiorenal risk factors (blood pressure, low-density lipoprotein cholesterol, glycated hemoglobin and albuminuria)

Sanchez AM, Papaleo E, Corti L, Santambrogio P, Levi S, Vigan P, et al

Following a proper tirzepatide diet plan with adequate protein intake might slightly increase your grocery budget, particularly if you increase protein consumption to the recommended 0.7 to 1 gram per pound of body weight

Using proprietary technology aimed at producing cost-effective semaglutide formulations